The Function of Transmembrane Protein 135 in Retinal Pigmented Epithelium
跨膜蛋白135在视网膜色素上皮中的功能
基本信息
- 批准号:10231869
- 负责人:
- 金额:$ 6.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcetyl-CoA CarboxylaseAffectAge related macular degenerationAgingAllelesApplications GrantsBlindnessCandidate Disease GeneChoroidCritical PathwaysDataDevelopmentDiabetic RetinopathyDiseaseEquilibriumEthylnitrosoureaEyeFatty AcidsFutureGene-ModifiedGenesGeneticGenetic TechniquesGenotypeGlaucomaGoalsHealthHomeostasisIn VitroIntegral Membrane ProteinLeadLearningLinkMalonyl Coenzyme AMapsMethodsMitochondriaMorphologyMusMutant Strains MiceMutationPathologyPathway interactionsPhenotypePrevalenceProcessProteinsResolutionRetinaRetinal DiseasesRisk FactorsRoleScleraStructureStructure of retinal pigment epitheliumTestingTherapeuticThickTrainingage relatedcongenicfatty acid oxidationforward geneticsin vivoinhibitor/antagonistmouse geneticsmutantnovel therapeuticsoverexpressionpositional cloningpreservationpreventtranscriptometranscriptomics
项目摘要
Project Abstract
Aging is a significant risk factor for retinal disease development but how aging predisposes an eye to
pathologies remains an unanswered question. One method to understand the role of aging in retinal disease
development is to identify key genetic factors that lead to accelerated aging retinal phenotypes in mice. Using
this method, transmembrane protein 135 (Tmem135) was identified as a gene important in retinal aging.
Tmem135 encodes a protein that can colocalize with mitochondria and regulate mitochondrial dynamics, the
collective process mitochondria undergo to preserve their structure and function. We hypothesize that proper
control of mitochondrial dynamics through TMEM135 is essential to maintain normal retinal function,
dysregulation of which leads to accelerated aging retinal pathologies. However, the mechanism of how
Tmem135 regulates mitochondrial dynamics and retinal aging is unknown. In this proposal, we explore the role
of Tmem135 in retinal pigmented epithelium (RPE) cells. RPE cells are thick, dense and small in Tmem135
mutant mice, whereas RPE cells are dysmorphogenic and degenerative in mice overexpressing wild-type
Tmem135 compared to their respective controls. These RPE changes correspond to opposing mitochondria
morphologies in these genotypes. These preliminary data indicate that RPE cells and their mitochondria are
sensitive to changes in TMEM135. The main goal of this training grant proposal is to learn and utilize mouse
genetic techniques in order to identify how TMEM135 maintains RPE and mitochondrial homeostasis. The
function of TMEM135 within RPE cells will be investigated using mouse genetic techniques through two aims.
In Aim 1, we will identify and validate candidate genes that modify the RPE phenotype induced by Tmem135
overexpression. In Aim 2, we will examine the relationship between TMEM135 and the malonyl-coenzyme A
(malonyl-CoA) pathway. Together, this proposal will further our understanding of TMEM135 function in the eye
and the role of aging in retinal disease development.
项目摘要
衰老是视网膜疾病发展的重要危险因素,但衰老如何使人眼中
病理仍然是一个未解决的问题。一种了解衰老在视网膜疾病中的作用的方法
发展是为了确定导致小鼠衰老的视网膜表型加速的关键遗传因素。使用
这种方法,跨膜蛋白135(TMEM135)被鉴定为在视网膜衰老中重要的基因。
TMEM135编码可以与线粒体共定位并调节线粒体动力学的蛋白质
集体过程线粒体会经历其结构和功能。我们假设这是正确的
通过TMEM135控制线粒体动力学对于维持正常视网膜功能至关重要,
失调导致衰老的视网膜病理加速。但是,如何
TMEM135调节线粒体动力学,视网膜衰老尚不清楚。在此提案中,我们探讨了角色
视网膜色素上皮(RPE)细胞中的TMEM135。 RPE细胞在TMEM135中厚,密集且小
突变小鼠,而RPE细胞在过表达野生型的小鼠中具有畸形和退化性
TMEM135与它们各自的对照相比。这些RPE变化对应于相反的线粒体
这些基因型中的形态。这些初步数据表明RPE细胞及其线粒体是
对TMEM135的变化敏感。该培训赠款建议的主要目标是学习和利用鼠标
遗传技术是为了确定TMEM135如何维持RPE和线粒体稳态。这
TMEM135在RPE细胞中的功能将通过小鼠遗传技术通过两个目标研究。
在AIM 1中,我们将识别和验证修改TMEM135诱导的RPE表型的候选基因
过表达。在AIM 2中,我们将研究TMEM135和丙二酰辅酶A之间的关系
(malonyl-COA)途径。这项建议将进一步了解我们对TMEM135功能的理解
以及衰老在视网膜疾病发展中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Landowski其他文献
Michael Landowski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
SIRT3-乙酰辅酶A羧化酶Ⅱ(ACC2)-肉碱脂酰转移酶(CPTI)参与增龄性房颤心房肌细胞损伤的机制研究
- 批准号:82371595
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
乙酰辅酶A羧化酶ACC1参与拟南芥蜡质合成响应盐胁迫的功能解析
- 批准号:32100207
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
乙酰辅酶A羧化酶(ACC)诱导EGFR突变肺癌三代EGFR-TKI耐药的机制研究
- 批准号:82172642
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
乙酰辅酶A羧化酶ACC1参与拟南芥蜡质合成响应盐胁迫的功能解析
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
异质型乙酰辅酶A羧化酶在固碳中的催化机制
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
AKR1a1 as a novel therapeutic target for Non-Alcoholic Fatty Liver Disease
AKR1a1作为非酒精性脂肪肝的新治疗靶点
- 批准号:
10385931 - 财政年份:2022
- 资助金额:
$ 6.64万 - 项目类别:
Modulating retinal lipid biogenesis in diabetes for therapeutic effects
调节糖尿病视网膜脂质生物合成以获得治疗效果
- 批准号:
10503919 - 财政年份:2022
- 资助金额:
$ 6.64万 - 项目类别:
AKR1a1 as a novel therapeutic target for Non-Alcoholic Fatty Liver Disease
AKR1a1作为非酒精性脂肪肝的新治疗靶点
- 批准号:
10559523 - 财政年份:2022
- 资助金额:
$ 6.64万 - 项目类别:
Modulating retinal lipid biogenesis in diabetes for therapeutic effects
调节糖尿病视网膜脂质生物合成以获得治疗效果
- 批准号:
10672366 - 财政年份:2022
- 资助金额:
$ 6.64万 - 项目类别:
Age-Related Obesity and Healthspan: Identifying Interventions and Mechanisms
与年龄相关的肥胖和健康寿命:确定干预措施和机制
- 批准号:
9171143 - 财政年份:2016
- 资助金额:
$ 6.64万 - 项目类别: